North America HLA Typing Transplantation Diagnostics Services Market is Expected to Grow Due to the Technological Advancements in HLA Typing in the Forecast Period 2018-2025

North America HLA Typing Transplantation Diagnostics Services Market is expected to register a CAGR of healthy rate in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.North America HLA Typing Transplantation Diagnostics Services MarketAccess Full Report: https://databridgemarketresearch.com/reports/north-america-hla-typing-transplant-diagnostics-services-market/

Segmentation: North America HLA Typing Transplantation Diagnostics Services Market

North America HLA Typing Transplantation Diagnostics Services Market By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), By Technique (Industry-Specific, Broad-B PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), PCR-SBT (Sequencing Based Typing) ased), By End-Users (Hospitals, Transplant Centers, Specialty Clinics, Academic Institutes), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Drivers: North America HLA Typing Transplantation Diagnostics Services Market

The major factors contributing to the growth of the market includes factors such as technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures and increased research grants, funds, and public-private investments.

TECHNOLOGICAL ADVANCEMENTS IN HLA TYPING

The human leukocyte antigen (HLA) compound comprises of the polymorphic genes in the human genome. The latest and advanced techniques such as next generation sequencing (NGS) technology have been evolved as an alternative method for Sequence Based Typing (SBT). The advantage of NGS comprises of single strand sequencing nature which combines the increased amount of sequencing reads in each sample and locus. The most significant property of NGS technologies includes a large amount of clonal sequences generation in a single sequencing run. The significant advancement in NGS making it a great potential to overcome traditional sequencing based HLA typing which ultimately resulted in revolutionary changes in HLA typing transplant diagnostics services.

  • The Roche 454 GS Junior, the Illumina Miseq and the Ion Torrent system have recently developed advanced NGS platform for HLA typing.
  • According to a study published in National Center for Biotechnology Information (NCBI), the SBT method has become more advanced as it uses an ABI Prism 3700 DNA analyzer; these are developed for high throughput production of sequence data through highly automated operation..
  • Roche, a pioneer in pharmaceuticals and diagnostics that is focused on advancing science to improve people’s lives, has introduced next-generation HLA typing solution for 454 sequencing systems, these are the GS GType HLA primer sets for high- and medium-resolution genotyping of class I and class II loci of the Human leukocyte antigen (HLA) genes.

INCREASING NUMBER OF SOLID ORGAN AND STEM CELL TRANSPLANTATION PROCEDURES

Organ transplantation is a surgical procedure in which a damaged or missing organ is removed and replaced with a functioning organ from other body (Donor).The location of the donor and recipient may vary. The organs can also be transported from a donor site to another location.

  • As per news published in Time Inc.,organ transplantations were performed in 2017 including organs from deceased as well as living donors. And the transplant performed in has noticed the record setting year for transplants consecutively for five years.
  • According to a study published in American Journal of Managed Care (AJMC), there were kidney transplants performed in the United States in the year 2012.

INCREASED RESEARCH GRANTS, FUNDS, AND PUBLIC-PRIVATE INVESTMENTS

The human leukocyte antigen (HLA) molecules are by the genes are present at the 3.6 Mb region on the chromosome. Genotyping of the human leucocyte antigen (HLA) is performed for the transplantation of hematopoietic stem cells or organs.

  • For instance, the U.S. government has planned to invest for helping in shortening the waiting list for patients for the organ transplants.
  • According to a publication in Department of Health and Human Services, the Funding Opportunity Announcement (FOA) which was issued by the National Institute on Aging (NIA), National Institutes of Health has invited the applications for proposing basic, translational, clinical, and epidemiological. And the research results on the solid organ transplant (SOT) in older persons have been raised.

Major Players: North America HLA Typing Transplantation Diagnostics Services Market

Some of the major players operating in th is market are Thermo Fisher Scientific Inc., Laboratory Corporation Of America Holdings, Proimmune Ltd,  Creative Biolabs, Histogenetics LLC and U C L A Immunogenetics Center among others.